China News Service, Beijing, September 14 (Reporter Chen Hang) The reporter learned from the Beijing Municipal Science and Technology Commission and the Zhongguancun Management Committee that Beijing's artificial intelligence industry continues to maintain rapid growth and has gradually become a new economic growth point in the capital.

According to incomplete statistics, the output value of artificial intelligence in 2021 will reach 207 billion yuan, a year-on-year increase of 11%; in 2022, Beijing's artificial intelligence-related output value is expected to be about 227 billion yuan, a year-on-year increase of 9.7%.

　　The 2022 Zhongguancun Forum will be held in Beijing from September 22 to 27. The main venue will be located at the National Convention Center, and branch venues will be set up in the Zhongguancun National Independent Innovation Demonstration Zone Exhibition Center.

A total of six major sections, including forum meetings, technology transactions, exhibitions, results releases, cutting-edge competitions, and supporting activities, have been set up, with a total of more than 130 events.

　　The forum will invite the world's top scientists, top institutions, and well-known innovative and entrepreneurial entities to participate in the forum, focusing on hot topics such as artificial intelligence, medicine and health, energy security, and carbon neutrality, to discuss the new trend of science and technology leading the development of human society.

　　In the exhibition and display section, the 2022 Zhongguancun Forum Exhibition (Science and Technology Expo) covers an area of ​​63,000 square meters. It will closely focus on the theme of the forum and showcase the technological innovation achievements of domestic and foreign institutions and enterprises.

Among them, the cutting-edge technology and future industry exhibition area is set up in the first-phase exhibition hall of the National Convention Center, with a total area of ​​22,000 square meters. It will focus on displaying artificial intelligence, integrated circuits, blockchain, quantum computing, cell and gene therapy, hydrogen energy and energy storage, etc. The latest cutting-edge achievements in the field.

　　As the first national pilot zone for the innovation and development of new-generation artificial intelligence, the scale of the artificial intelligence industry has grown rapidly, and a basically complete industrial chain has been formed. It is rapidly building an industrial ecosystem with global influence. The number of national new-generation artificial intelligence open innovation platforms , the number of AI scholars, the number of papers published and patent applications, the number of AI-related companies, the total amount of financing in the AI ​​field, and the number of financing events and other development indicators are leading in the country.

　　During this Zhongguancun Forum, Megvii's algorithm production platform AIS, intelligent pallet four-way vehicle system, and urban operation center IOC and other innovative achievements and technical products will be unveiled.

In terms of forum meetings, Megvii will also discuss the construction of artificial intelligence open ecology and the use of artificial intelligence to help the high-quality development of the real economy, as well as share Megvii's thinking and practice in technology entrepreneurship innovation and responsible AI development.

　　The relevant person in charge of Megvii said that for all science and technology enterprises, the Zhongguancun Forum is an excellent platform to demonstrate their capabilities and strengths, get close contact with the world's most sophisticated scientific and technological achievements, broaden their horizons of innovation, and promote industrial exchanges and cooperation. .

　　During the Zhongguancun Forum, Beijing Microchip Blockchain and Edge Computing Research Institute, a new R&D institution in Beijing, will build a blockchain sector exhibition area in the core exhibition area of ​​the Science and Technology Expo, and systematically present the R&D ecology and technology of Changan Chain, which is innovatively developed in my country. Results, application scenarios, collaborative networks.

　　In addition, at the Zhongguancun Forum, Microchip will also hold the "Blockchain + Privacy Computing Development Forum", focusing on the potential and value of blockchain technology combined with privacy computing technology in promoting technological innovation, developing the digital economy, and empowering the real economy. , will invite top scientists at home and abroad to discuss the development trend of blockchain and privacy computing. Central enterprises and key enterprises in Beijing will share their innovative practical achievements in the field of blockchain, and talk about the application future of blockchain and privacy computing.

　　In 2021, the Beijing Municipal Science and Technology Commission and the Zhongguancun Administrative Committee took the lead in formulating a new round of "Beijing Medicine and Health Collaborative Innovation Action Plan (2021-2023)" to continue the inertia and momentum of high-quality development, and improve the quality and speed of industrial development. Continued efforts.

　　It is reported that there will be 20 new listed pharmaceutical companies in Beijing in 2021, the highest in the past three years, and 6 new listed companies will be added in the first half of 2022.

There are 7 medical devices that have entered the national innovative device review channel and have been approved for listing, and 7 AI Class III medical device products have been approved for listing, ranking first in the country in number.

　　During the forum, Keya Medical's AI clinical precision diagnosis and treatment innovative application solutions such as Shenmai Score and Shenmai Ling Analysis will be unveiled.

According to Wang Liwei, Chairman and CEO of Keya Medical, the “Deep Pulse Fractional DVFFR” developed by Keya Medical is the world’s first product that uses deep learning technology to evaluate coronary physiological function.

It uses the numerical analysis of coronary computed tomography angiography images to quickly assess whether coronary stenosis will lead to myocardial ischemia, thereby assisting doctors in the next step of diagnosis and treatment.

　　Wang Liwei said that in August 2021, Keya Medical and Anzhen Hospital signed a contract to establish a medical-enterprise joint laboratory, and Keya Medical's deep pulse fraction DVFFR was officially put into clinical use in Beijing Anzhen Hospital.

Up to now, nearly 5,000 patients have been served, and a total of more than 1,000 people have avoided unnecessary coronary angiography operations, saving patients about 20 million yuan in medical expenses.

(Finish)